夏庞蒂耶（Emmanuelle Charpentier）和道纳（Jennifer A. Doudna）因开发出一种高效的基因组编辑手段——CRISPR/Cas9基因剪刀——而荣获 ...

CRISPR革命始于2012年，当时诺贝尔奖得主詹妮弗·杜德纳（Jennifer Doudna）和艾曼纽·查彭蒂耶（Emmanuelle Charpentier）发表了他们发现的一种新的基因编辑 ...

CRISPR stocks are high risk but hold potential for aggressive investors. CRISPR Therapeutics and its partner Vertex Pharmaceuticals have the only approved CRISPR therapy. Several other biotech ...

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.

Crispr Therapeutics, in collaboration with Vertex, pioneered the first CRISPR-based gene therapy, Casgevy, with regulatory approval in multiple countries, poised for strong revenue growth from Q4 ...

2024年12月16日，生命科学学院刘亮教授团队在《Nucleic Acids Research》期刊上在线发表了题为“DNA target binding-induced pre-crRNA processing in type II and V CRISPR-Cas systems”的研究论文，首次揭示了靶标核酸的 ...

CRISPR革命始于2012年，当时诺贝尔奖得主詹妮弗·杜德纳（Jennifer Doudna）和艾曼纽·查彭蒂耶（Emmanuelle Charpentier）发表了他们发现的一种新的基因编辑 ...

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR ...